Human cytomegalovirus (HCMV) infections of immunocompetent hosts are characterized by a dynamic, life-long interaction in which host immune responses, particularly of T cells, restrain viral replication and prevent disease but do not eliminate the virus or preclude transmission. Because HCMV is among the largest and most complex of known viruses, the T cell resources committed to maintaining this balance have never been characterized completely. Here, using cytokine flow cytometry and 13,687 overlapping 15mer peptides comprising 213 HCMV open reading frames (ORFs), we found that 151 HCMV ORFs were immunogenic for CD4+ and/or CD8+ T cells, and that ORF immunogenicity was influenced only modestly by ORF expression kinetics and function. We further documented that total HCMV-specific T cell responses in seropositive subjects were enormous, comprising on average ∼10% of both the CD4+ and CD8+ memory compartments in blood, whereas cross-reactive recognition of HCMV proteins in seronegative individuals was limited to CD8+ T cells and was rare. These data provide the first glimpse of the total human T cell response to a complex infectious agent and will provide insight into the rules governing immunodominance and cross-reactivity in complex viral infections of humans.
Skip Nav Destination
Article navigation
5 September 2005
Article|
September 06 2005
Broadly targeted human cytomegalovirus-specific CD4 + and CD8 + T cells dominate the memory compartments of exposed subjects
Andrew W. Sylwester,
Andrew W. Sylwester
1Vaccine and Gene Therapy Institute, Departments of Pathology and Molecular Microbiology and Immunology, and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
Search for other works by this author on:
Bridget L. Mitchell,
Bridget L. Mitchell
1Vaccine and Gene Therapy Institute, Departments of Pathology and Molecular Microbiology and Immunology, and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
Search for other works by this author on:
John B. Edgar,
John B. Edgar
1Vaccine and Gene Therapy Institute, Departments of Pathology and Molecular Microbiology and Immunology, and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
Search for other works by this author on:
Cara Taormina,
Cara Taormina
1Vaccine and Gene Therapy Institute, Departments of Pathology and Molecular Microbiology and Immunology, and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
Search for other works by this author on:
Christian Pelte,
Christian Pelte
1Vaccine and Gene Therapy Institute, Departments of Pathology and Molecular Microbiology and Immunology, and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
Search for other works by this author on:
Franziska Ruchti,
Franziska Ruchti
1Vaccine and Gene Therapy Institute, Departments of Pathology and Molecular Microbiology and Immunology, and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
Search for other works by this author on:
Paul R. Sleath,
Paul R. Sleath
2Corixa Corporation, Seattle, WA 98104
Search for other works by this author on:
Kenneth H. Grabstein,
Kenneth H. Grabstein
2Corixa Corporation, Seattle, WA 98104
Search for other works by this author on:
Nancy A. Hosken,
Nancy A. Hosken
2Corixa Corporation, Seattle, WA 98104
Search for other works by this author on:
Florian Kern,
Florian Kern
3Institut für Medizinische Immunologie, Charité, 10098 Berlin, Germany
Search for other works by this author on:
Jay A. Nelson,
Jay A. Nelson
1Vaccine and Gene Therapy Institute, Departments of Pathology and Molecular Microbiology and Immunology, and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
Search for other works by this author on:
Louis J. Picker
Louis J. Picker
1Vaccine and Gene Therapy Institute, Departments of Pathology and Molecular Microbiology and Immunology, and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
Search for other works by this author on:
Andrew W. Sylwester
1Vaccine and Gene Therapy Institute, Departments of Pathology and Molecular Microbiology and Immunology, and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
Bridget L. Mitchell
1Vaccine and Gene Therapy Institute, Departments of Pathology and Molecular Microbiology and Immunology, and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
John B. Edgar
1Vaccine and Gene Therapy Institute, Departments of Pathology and Molecular Microbiology and Immunology, and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
Cara Taormina
1Vaccine and Gene Therapy Institute, Departments of Pathology and Molecular Microbiology and Immunology, and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
Christian Pelte
1Vaccine and Gene Therapy Institute, Departments of Pathology and Molecular Microbiology and Immunology, and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
Franziska Ruchti
1Vaccine and Gene Therapy Institute, Departments of Pathology and Molecular Microbiology and Immunology, and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
Paul R. Sleath
2Corixa Corporation, Seattle, WA 98104
Kenneth H. Grabstein
2Corixa Corporation, Seattle, WA 98104
Nancy A. Hosken
2Corixa Corporation, Seattle, WA 98104
Florian Kern
3Institut für Medizinische Immunologie, Charité, 10098 Berlin, Germany
Jay A. Nelson
1Vaccine and Gene Therapy Institute, Departments of Pathology and Molecular Microbiology and Immunology, and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
Louis J. Picker
1Vaccine and Gene Therapy Institute, Departments of Pathology and Molecular Microbiology and Immunology, and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
CORRESPONDENCE Louis J. Picker: [email protected]
Abbreviations used: CFC, cytokine flow cytometry; dPBS, Dulbecco's PBS; HCMV, human cytomegalovirus; IE, immediate-early; ORF, open reading frame.
Received:
May 04 2005
Accepted:
July 25 2005
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2005
J Exp Med (2005) 202 (5): 673–685.
Article history
Received:
May 04 2005
Accepted:
July 25 2005
Connected Content
This article has been corrected
Correction
Citation
Andrew W. Sylwester, Bridget L. Mitchell, John B. Edgar, Cara Taormina, Christian Pelte, Franziska Ruchti, Paul R. Sleath, Kenneth H. Grabstein, Nancy A. Hosken, Florian Kern, Jay A. Nelson, Louis J. Picker; Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects . J Exp Med 5 September 2005; 202 (5): 673–685. doi: https://doi.org/10.1084/jem.20050882
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Connected Content
Advertisement